Boston, MA, United States of America

Renald Thinard

This inventor holds 1 USPTO granted patent. Top assignee: Riesner Verwaltungs Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Renald Thinard. Retrieved from https://idiyas.com/inventor/renald-thinard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Renald Thinard: Innovator in Medical Chemistry

Introduction

Renald Thinard is a notable inventor based in Boston, MA, who has made significant contributions to the field of medical chemistry. His work primarily focuses on the development of innovative compounds that have the potential to address serious health conditions.

Latest Patents

Thinard holds a patent for "Polyvalent derivatives of emoxypine." This patent describes the use of polyvalent emoxypine derivatives or related compounds in the treatment or prevention of various diseases, including Parkinson's Disease. His innovative approach in this area showcases his commitment to advancing medical science.

Career Highlights

Renald Thinard is associated with Riesner Verwaltungs GmbH, where he continues to explore new avenues in medical research. His dedication to innovation has positioned him as a key figure in the development of therapeutic solutions.

Collaborations

Throughout his career, Thinard has collaborated with esteemed colleagues such as Claude Nicolau and Jean-Marie Lehn. These partnerships have enriched his research and contributed to the advancement of his projects.

Conclusion

Renald Thinard's work exemplifies the spirit of innovation in the medical field. His contributions, particularly in the development of emoxypine derivatives, hold promise for improving treatment options for patients with Parkinson's Disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…